Home LiteratureArticle Details
PMID: 7547247 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs.

British journal of cancer ·Vol. 72 ·No. 4 ·1995-10-00 ·Pages 952-7

Malcomson RD, Oren M, Wyllie AH, Harrison DJ

Abstract

Many recent studies have implicated p53 in the cellular response to injury and induction of cell death by apoptosis. In a rat embryonal fibroblast cell line transformed with c-Ha-ras and a mutant temperature-sensitive p53 (val135), cells were G1 arrested at the permissive temperature of 32 degrees C when overexpressed p53 was in wild-type conformation. In this state cells were resistant to apoptosis induced by etoposide (at up to 50 microM) or bleomycin (15 microU ml-1). Cells at 37 degrees C with overexpressed p53 in mutant conformation were freed from this growth arrest, continued proliferating and showed dose-dependent increases in apoptosis. This death is independent of wild-type p53 function. Control cells containing a non-temperature-sensitive mutant p53 (phe132) were sensitive to both etoposide and bleomycin after 24 h at 32 degrees C and 37 degrees C, indicating that the results are not simply due to temperature effects on pharmacokinetics or DNA damage. Our data show that induction of a stable p53-mediated growth arrest renders these cells much less likely to undergo apoptosis in response to certain anti-cancer drugs, and we conclude that the regulatory role of p53 in apoptosis is influenced by the particular cellular context in which this gene is expressed.

MeSH Terms
Animals Antineoplastic Agents/pharmacology Apoptosis/drug effects Bleomycin/pharmacology Cells, Cultured Etoposide/pharmacology Fibroblasts/drug effects Genes, p53/physiology Rats Temperature
Chemicals
Antineoplastic Agents Bleomycin Etoposide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Malcomson R D
Department of Pathology, University of Edinburgh Medical School, UK.
Oren M
Wyllie A H
Harrison D J
References (48)
48 references, click to expand
  1. Molecular mechanisms of drug resistance in tumours.
    J Pathol. 1995 Jan;175(1):7-12 PMID: 7891229
  2. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
    Genes Dev. 1994 Dec 1;8(23):2817-30 PMID: 7995520
  3. Lymphocyte apoptosis--mechanisms and implications in disease.
    Immunol Rev. 1994 Dec;142:141-56 PMID: 7698792
  4. Cell death in health and disease: the biology and regulation of apoptosis.
    Semin Cancer Biol. 1995 Feb;6(1):3-16 PMID: 7548839
  5. Preferential damage of active chromatin by bleomycin.
    Cancer Res. 1981 Jun;41(6):2439-43 PMID: 6165462
  6. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.
    Cytometry. 1983 Mar;3(5):323-7 PMID: 6188586
  7. Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2076-80 PMID: 2832845
  8. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.
    Science. 1988 Jul 15;241(4863):317-22 PMID: 3291120
  9. A genetic model for colorectal tumorigenesis.
    Cell. 1990 Jun 1;61(5):759-67 PMID: 2188735
  10. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
    Proc Natl Acad Sci U S A. 1990 Aug;87(16):6166-70 PMID: 2143581
  11. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Cell. 1990 Aug 24;62(4):671-80 PMID: 2143698
  12. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  13. p53 functions as a cell cycle control protein in osteosarcomas.
    Mol Cell Biol. 1990 Nov;10(11):5772-81 PMID: 2233717
  14. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Nature. 1990 Nov 22;348(6299):334-6 PMID: 2250705
  15. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
    Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
  16. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  17. Induction of apoptosis in fibroblasts by c-myc protein.
    Cell. 1992 Apr 3;69(1):119-28 PMID: 1555236
  18. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes.
    Exp Cell Res. 1992 Jun;200(2):416-24 PMID: 1315287
  19. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9 PMID: 1584781
  20. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 PMID: 1323840
  21. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
    Cell. 1992 Sep 18;70(6):923-35 PMID: 1356076
  22. Apoptosis induced by anticancer drugs.
    Cancer Metastasis Rev. 1992 Sep;11(2):121-39 PMID: 1327566
  23. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.
    Cancer Res. 1992 Oct 1;52(19):5407-11 PMID: 1394146
  24. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.
    Cell. 1992 Sep 18;70(6):937-48 PMID: 1525830
  25. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  26. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.
    Mol Cell Biol. 1993 Jan;13(1):711-9 PMID: 8417361
  27. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
    Blood. 1993 Jan 1;81(1):151-7 PMID: 8417786
  28. p53-mediated cell death: relationship to cell cycle control.
    Mol Cell Biol. 1993 Mar;13(3):1415-23 PMID: 8441387
  29. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2.
    Mol Cell Biol. 1993 Apr;13(4):2432-40 PMID: 8455620
  30. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
    Genes Dev. 1993 Apr;7(4):546-54 PMID: 8384580
  31. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  32. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  33. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents.
    Blood. 1993 Aug 15;82(4):1092-6 PMID: 8353276
  34. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.
    Cancer Res. 1993 Sep 15;53(18):4164-8 PMID: 8364909
  35. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.
    Cell. 1993 Sep 24;74(6):957-67 PMID: 8402885
  36. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.
    Cell. 1993 Oct 22;75(2):229-40 PMID: 8402909
  37. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  38. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression.
    Mol Cell Biol. 1993 Dec;13(12):7942-52 PMID: 8247009
  39. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):413-7 PMID: 8278402
  40. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    Cancer Res. 1994 Mar 1;54(5):1169-74 PMID: 8118801
  41. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.
    Cancer Res. 1994 Mar 15;54(6):1596-603 PMID: 8137265
  42. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
    Cell. 1994 Mar 25;76(6):1013-23 PMID: 8137420
  43. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal.
    EMBO J. 1994 Mar 15;13(6):1368-74 PMID: 8137820
  44. p53 and E2F-1 cooperate to mediate apoptosis.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3602-6 PMID: 8170954
  45. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
    Oncogene. 1994 Jun;9(6):1527-36 PMID: 8183546
  46. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
    Cancer Res. 1994 Jul 15;54(14):3718-22 PMID: 8033090
  47. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.
    Cell. 1994 Oct 21;79(2):329-39 PMID: 7954799
  48. Growth factor modulation of p53-mediated growth arrest versus apoptosis.
    Genes Dev. 1995 Mar 1;9(5):600-11 PMID: 7698649
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
1995-10-00
Pages
952-7
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2034034
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com